These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26833282)

  • 1. Fluidizing and Solidifying Effects of Perfluorooctylated Fatty Alcohols on Pulmonary Surfactant Monolayers.
    Nakahara H
    J Oleo Sci; 2016; 65(2):99-109. PubMed ID: 26833282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorocarbon-hybrid pulmonary surfactants for replacement therapy--a Langmuir monolayer study.
    Nakahara H; Lee S; Krafft MP; Shibata O
    Langmuir; 2010 Dec; 26(23):18256-65. PubMed ID: 21049919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA).
    Nakahara H; Lee S; Sugihara G; Chang CH; Shibata O
    Langmuir; 2008 Apr; 24(7):3370-9. PubMed ID: 18315015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of fluorocarbons in lung surfactant therapy.
    Gerber F; Krafft MP; Vandamme TF; Goldmann M; Fontaine P
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):211-20. PubMed ID: 17453705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluidization of a dipalmitoyl phosphatidylcholine monolayer by fluorocarbon gases: potential use in lung surfactant therapy.
    Gerber F; Krafft MP; Vandamme TF; Goldmann M; Fontaine P
    Biophys J; 2006 May; 90(9):3184-92. PubMed ID: 16500985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfacial behavior of pulmonary surfactant preparations containing egg yolk lecithin.
    Nakahara H; Shibata O
    J Oleo Sci; 2014; 63(11):1159-68. PubMed ID: 25296574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of fluorination effect on physical properties of saturated long-chain alcohols by DSC and Langmuir monolayer.
    Nakahara H; Nakamura S; Okahashi Y; Kitaguchi D; Kawabata N; Sakamoto S; Shibata O
    Colloids Surf B Biointerfaces; 2013 Feb; 102():472-8. PubMed ID: 23107937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysteresis behavior of amphiphilic model peptide in lung lipid monolayers at the air-water interface by an IRRAS measurement.
    Nakahara H; Dudek A; Nakamura Y; Lee S; Chang CH; Shibata O
    Colloids Surf B Biointerfaces; 2009 Jan; 68(1):61-7. PubMed ID: 18977123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution.
    Krafft MP; Riess JG
    Biochimie; 1998; 80(5-6):489-514. PubMed ID: 9782389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties.
    Bae CW; Chung SH; Choi YS
    Yonsei Med J; 2016 Jan; 57(1):203-8. PubMed ID: 26632402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
    Zuo YY; Veldhuizen RA; Neumann AW; Petersen NO; Possmayer F
    Biochim Biophys Acta; 2008 Oct; 1778(10):1947-77. PubMed ID: 18433715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of the interfacial properties of lung surfactant with a newly designed hydrocarbon/fluorocarbon lipid.
    Dilli G; Unsal H; Uslu B; Aydogan N
    Colloids Surf B Biointerfaces; 2014 Oct; 122():566-575. PubMed ID: 25112907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detrimental effect of serum albumin on the re-spreading of a dipalmitoyl phosphatidylcholine Langmuir monolayer is counteracted by a fluorocarbon gas.
    Gerber F; Krafft MP; Vandamme TF
    Biochim Biophys Acta; 2007 Mar; 1768(3):490-4. PubMed ID: 17097604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.